Trial of IV NTG for CD After Second Stage Arrest for the Prevention of Uterine Extension
- Conditions
- Prolonged Second Stage of Labor
- Interventions
- Registration Number
- NCT02265965
- Lead Sponsor
- University of California, San Francisco
- Brief Summary
Randomized controlled clinical trial of IV nitroglycerin at cesarean delivery for second stage arrest of descent to prevent or uterine extension at the hysterectomy site.
- Detailed Description
Intravenous nitroglycerin resulting in uterine relaxation has been standardly utilized for various obstetrics conditions, e.g. breech extraction of second twin in vaginal deliveries, uterine relaxation after tachysystole in labor, prior to external cephalic version, and during difficult fetal extraction during cesarean delivery for arrest of descent in labor. Currently the use of nitroglycerin is at equipoise in obstetrics for difficult cesarean delivery after second stage arrest in labor. The clinical trial will randomize women who undergo cesarean delivery for second stage arrest in labor to receive IV nitroglycerin vs saline at the time of hysterotomy. The primary outcomes will be maternal: uterine extension, blood loss, total fetal extraction time, surgical time; neonatal: cord gases at delivery, apgar scores, admission to neonatal intensive care unit.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 18
women 37weeks or greater gestation diagnosed with second stage arrest of descent undergoing cesarean delivery -
elective, active phase arrest cesarean delivery, successful operative vaginal delivery
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intravenous Nitroglycerin intravenous nitroglycerin Subjects will receive IV nitroglycerin at the time of Hysterotomy. Infusion will be stopped once neonate is delivered
- Primary Outcome Measures
Name Time Method Number of Participants With Uterine Extension of Hysterotomy During cesarean delivery, estimated to be within 4 hours after diagnosis of second stage arrest Obstetrician determined whether the subject had an uterine extension.
Umbilical Artery Blood pH At time of cesarean delivery, estimated to be within 4 hours after diagnosis of second stage arrest Measure of umbilical artery blood pH
Number of Participants With Deliveries After Which Neonate is Admitted to NICU After cesarean delivery, estimated to be within 4 hours after diagnosis of second stage arrest Number of Participants With Deliveries in Which Cord Blood Base Deficit is More Negative Than or Equal to Negative 12 At time of cesarean delivery, estimated to be within 4 hours after diagnosis of second stage arrest A cord blood base deficit more negative than negative 12 is abnormal and a sign of metabolic acidosis.
APGAR at 5 Minutes Immediately after cesarean delivery, estimated to be within 4 hours after diagnosis of second stage arrest The APGAR scale is determined by evaluating the newborn baby on five simple criteria -- Appearance, Pulse, Grimace, Activity, Respiration -- on a scale from zero to two, then summing up the five values thus obtained. The resulting APGAR score ranges from zero to 10. Zero is the worst possible score and 10 is the highest possible score.
- Secondary Outcome Measures
Name Time Method Fetal Extraction Time in Seconds At time of cesarean delivery, estimated to be within 4 hours after diagnosis of second stage arrest Time from uterine incision to delivery (body of neonate fully extracted from uterus)
Total Operative Time in Minutes After cesarean delivery, estimated to be within 4 hours after diagnosis of second stage arrest Time from uterine incision to out of room
Surgical Blood Loss During and after cesarean delivery, estimated to be within 4 hours after diagnosis of second stage arrest Total blood loss will be measured
Trial Locations
- Locations (1)
University California San Francisco-Labor and Delivery
🇺🇸San Francisco, California, United States